Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love HealthStream, Inc. (HSTM)?

Page 1 of 2

Is it smart to be bullish on HealthStream, Inc. (NASDAQ:HSTM)?

In the 21st century investor’s toolkit, there are tons of indicators market participants can use to analyze their holdings. A couple of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best fund managers can outclass the broader indices by a very impressive amount (see just how much).

Just as crucial, optimistic insider trading sentiment is another way to look at the financial markets. As the old adage goes: there are a variety of motivations for a bullish insider to cut shares of his or her company, but just one, very clear reason why they would behave bullishly. Various empirical studies have demonstrated the impressive potential of this strategy if you understand where to look (learn more here).

HealthStream, Inc. (NASDAQ:HSTM)

Now that that’s out of the way, let’s study the latest info about HealthStream, Inc. (NASDAQ:HSTM).

What does the smart money think about HealthStream, Inc. (NASDAQ:HSTM)?

In preparation for the third quarter, a total of 11 of the hedge funds we track were long in this stock, a change of 10% from one quarter earlier. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes significantly.

Out of the hedge funds we follow, Archon Capital Management, managed by Constantinos J. Christofilis, holds the biggest position in HealthStream, Inc. (NASDAQ:HSTM). Archon Capital Management has a $15.6 million position in the stock, comprising 7.1% of its 13F portfolio. Sitting at the No. 2 spot is Richard Driehaus of Driehaus Capital, with a $4.9 million position; 0.2% of its 13F portfolio is allocated to the company. Remaining hedge funds that hold long positions include Jim Simons’s Renaissance Technologies, Chuck Royce’s Royce & Associates and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Now, specific money managers were breaking ground themselves. Archon Capital Management, managed by Constantinos J. Christofilis, created the biggest position in HealthStream, Inc. (NASDAQ:HSTM). Archon Capital Management had 15.6 million invested in the company at the end of the quarter. Richard Driehaus’s Driehaus Capital also made a $4.9 million investment in the stock during the quarter. The other funds with brand new HSTM positions are Jim Simons’s Renaissance Technologies, Chuck Royce’s Royce & Associates, and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Insider trading activity in HealthStream, Inc. (NASDAQ:HSTM)

Insider buying made by high-level executives is best served when the company we’re looking at has experienced transactions within the past half-year. Over the latest six-month time frame, HealthStream, Inc. (NASDAQ:HSTM) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to HealthStream, Inc. (NASDAQ:HSTM). These stocks are Bitauto Hldg Ltd (ADR) (NYSE:BITA), Group Inc (NASDAQ:WWWW), Move Inc. (NASDAQ:MOVE), SouFun Holdings Limited (ADR) (NYSE:SFUN), and Blucora Inc (NASDAQ:BCOR). This group of stocks are the members of the internet information providers industry and their market caps are similar to HSTM’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!